Keith Lovell joined Antidote as CFO in September 2015, bringing more than 25 years of financial and commercial experience at companies ranging from ...
Continue readingAccelerating clinical studies is a mission that affects us all.
Keith Lovell joined Antidote as CFO in September 2015, bringing more than 25 years of financial and commercial experience at companies ranging from ...
Continue readingThe Scrip Awards are where the industry’s best and brightest are recognized for excellence across the drug development spectrum. That’s why we’re ...
Continue readingA few years ago, we wrote a blog series for ACRP in which we focused on patient centricity in clinical trial design, recruitment, and execution. Over ...
Continue readingClinical research organizations sometimes create surveys and share general statistics about clinical trial participation. But every patient is ...
Continue readingToday, nearly 60 million patients are needed for currently recruiting clinical trials. And in fact, 80% of trials will be delayed or closed due to ...
Continue readingAs medications become more targeted and sophisticated, the growing complexity of clinical trial protocols is making it more difficult than ever to ...
Continue readingWhile approximately 15 to 20 percent of people 65+ have Mild Cognitive Impairment (MCI), it can be difficult to identify, and difficult to determine ...
Continue readingToday, 70% of the 18 million adults in the U.S. experience moderate-to-severe symptoms. Nearly half of people with eczema report that they "often" or ...
Continue readingA few years ago, we wrote a blog series for ACRP in which we focused on patient centricity in clinical trial design, recruitment, and execution. Over ...
Continue readingAn estimated 5.8 million people in the United States have been diagnosed with Alzheimer's disease. As the millions of patients and caregivers around ...
Continue reading